Sponsor content
851 result(s) found, displaying 431 to 440
-
Prescription medicine decision summaryTGA decision: Bevacip/Bevaciptin (bevacizumab) is approved to treat various types of cancers.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHENYLEPHRINE CIPLA phenylephrine hydrochloride 10 mg / 1 mL injection USP vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHENYLIP phenylephrine hydrochloride 10 mg / 1 mL injection USP vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VASOPHEN phenylephrine hydrochloride 10 mg / 1 mL injection USP vial.
-
Prescription medicine registrationActive ingredients: bevacizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA LENALIDOMIDE lenalidomide 20 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALIMID lenalidomide 5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALIMID lenalidomide 10 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALIMID lenalidomide 15 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALIMID lenalidomide 20 mg capsule blister pack.